Wk 3: Jaundice, prematurity and low birth weight/IUGR Flashcards

1
Q

What jaundice?

A

= juandice/hyperbilirubinaemia as a result from an imbalance between bilirubin production, conjugation and elimination.

Presents as yellow discolouration of the skin, mucous membranes and sclera/conjunctiva.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the pathophysiology of general jaundice.

A
  • Jaundice/hyperbilirubinaemia is a results from an imbalance between bilirubin production, conjugation and elimination.
  • The breakdown of RBCs and haemoglobin causes unconjugated bilirubin to accumulate in the blood (not water soluble) and is neurotoxic.
  • Unconjugated bilirubin binds to albumin and is transported to the liver where it is converted to conjugated bilirubin.
  • Conjugated bilirubin is water soluble and able to be eliminated via urine and faeces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference between pathological and physiological jaundice and when do they most commonly occur?

A

Pathological jaundice occurs when the liver correctly conjugated bilirubin for excretion, however there is a problem with excretion.
- an issue of once conjugated
- occurs within 24hrs and can persist greater than 14 days

Physiological is related to the immaturity of the liver and inability to process bilirubin at a rate that is equating to its production.
- an issue before conjugated thus more dangerous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is jaundice dangerous?

A
  • if left unbound and thus uncongufated, bilirubin can cross the blood-brain barrier as it is lipid soluble and thus be toxic to the brain protetially causing Kernicterus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What can factors impact severity of jaundice?

A
  • gestation (relateing to lover development)
  • trauma (relating to increased brusing and thus dead blood cells)
  • feeding ability
  • race
  • family factors
  • gener (more common in males)
  • time of first breastfeed (earlier the better)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Should breastfeeding be stopped if a baby has breast milk jaundice?

A
  • Not neccessarity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Other than immature liver and compromised excretion, what are some other causes of jaundice?

A
  • Spesisi, though neoate usually presents unwell as well as jaundice
  • Haemolysis from blood group incompatability and red cell defects e.g. ABO incompatibility, Rh isoimmunised
  • Excessive, non-haemolytic red cell destruction e.g. bruising, cephalhaematoma
  • GI tract obstruction or ileus
  • Prematurity
  • Hypothyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is conjugated bilirubinemia (pathological) a risk?

A
  • because we are unsure what is causing it. It is the underlying obstruction in excretion that is of concern.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some key differentiations making a jaundice an issue of pathological vs physiological? and what are their respective risks.

A

Pathological: only related to issues of congugated bilirubin.
- risk of underlying cause
- if jaundice present before - 24hrs or after 24 days it is likely pathological.

Physiological: always an issue of uncongugated.
- risk of toxic uncongugated crossing the blood brain barrier.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some causes of pathological jaundice?

A
  • Obstruction of the large and/or small branches of the biliary tree.
  • biliary atresia
    - Result in bile ducts being absent causing an obstructive jaundice
    - Best operated before 45-60 days of life
    - These newborns usually have pale, clay-coloured stools and dark urine.
  • Choledochal/Common bile duct cyst
  • Neonatal hepatitis e.g. congenital infection - toxoplasmosis, rubella, cytomegalovirus, herpes, syphilis
    Metabolic
    - galactossaemia
    - fructose intolerance
  • Complication of Total Parental Nutrition (TPN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some diseases resulting in hyperbilirubinaemia?

A

Glucose-6-Phosphate Dehydrogenase deficiency (G6PD)

Pyruvate Kinase Deficiency (PK)

Hereditary spherocytosis (HS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain Glucose-6-Phosphate Dehydrogenase deficiency (G6PD)

A

= common enzyme deficiency
the primary function of G6PD is to stabilise the RBC membrane and protect it from oxidative damage which may lead to haemolysis if damage occurs.
- can cause extreme hyperbilirubinaemia +/- acute bilirubin encephalopathy.
- X-linked recessive disorder mostly affecting males
- complete absence of G6PD is incompatible with life
- jaundice may subside spontaneously, require phototherapy and occasionally require an exchange transfusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain Pyruvate Kinase Deficiency (PK)

A

= common glycolytic (relating to or causing glycolysis) defect causing non-spherocytic haemolytic anaemia
- PK is crucial to energy production, responsible for nearly 50% of the neonates total ATP
- Lack of ATP may lead to severe neonatal anaemia and early hyperbilirubinaemia
- DAT negative
results in severe haemolytic crises and hyperbilirubinaemia
- in some circumstances, newborns may be severely anaemic or even die in-utero
- in those born alive, anaemia and severe jaundice may result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain hereditary spherocytosis (HS)

A
  • common hereditary RBC membrane defect leading to acute haemolysis in the newborn
  • this condition results in RBC shape being spherical instead of biconcave as a result of loss of membrane surface area relative to intracellular volume
  • autosomal dominant condition predominantly but at times may be recessive or due to mutations
  • the deficiency results in RBC with higher metabolic requirements that are trapped prematurely in the spleen and destroyed.
  • may be associated with hyperbilirubinaemia in the first day of life or kernicterus which occurs suddenly as the immune system recognises the abnormal cells.
    a blood test will show spherocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain the pathophysiology of bilirubin-induced neurotoxicity and encephalopathy

A

= The “blood-brain barrier” of the neonate, especially the premature neonate, is unable to defend the brain against unconjugated bilirubin, which is toxic to the nerve cells in the basal ganglia, hippocampus and substantia nigra as well as the auditory pathways and oculomotor nucleus.

  • may leads to kernicterus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some signs of acute bilirubineia encephalopathy?

A
  • Lethargy
  • Poor feeding
  • Temperature instability
  • Hypotonia
  • Arching of the head, neck and back
  • Spasticity
  • Seizures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define kernicterus

A

= yellow staining of the brain cells and even permanent death, particularly in the grey matter of the brain.
- There is necrosis of the neurons in the basal ganglia leading to irreversible neuro disabilities.
- Kernicterus is the chronic and permanent result of bilibilirubin-induced neurological dysfunction
- There is no safe level of Serum bilirubin for where toxicity occurs and pre-term neonates are more susceptible than term neonates due to an immature central nervous system and neuronal pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain the cephalocaudal manner and kramers rule

A

the progression of jaundice yellowing from the
- eyes and face (1 ~100)
- chest and upper abdo (2 ~150)
- lower abdo/pelvis (3 ~200)
- legs and upper arms (4 ~250)
- hands a feets (5 ~>257)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the benififts of a TCB?

A
  • fast
  • non invasive
  • most accurate at the lower levels of hyperbilirubinaemia
  • useful for assessing infants who are jaundiced and more than 24 hours of age without risk factors for developing severe hyperbilirubinemia.
  • if within 50mmol/L of threshold then do formal SBR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the treatment of jaundice?

A
  • Treating cause e.g. infection
  • Ascertain adequate and effective breast/bottle feeding to reduce the enterohepatic circulation of bilirubin.
  • Breast fed newborns should feed effectively 8-12 times per day
  • IV fluids may be considered if oral input poor
  • Phototherapy
  • Exchange transfusion
  • IV immunoglobulin to newborns with isoimmune haemolytic disease and rising bilirubin despite intensive phototherapy or in close range for an exchange transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the JAUNDICE neumonic for remebering risk of jaundice?

A

J - jaundice within the first 24 hours
A - a sibling who required phototherapy in the neonatal period
U - unrecognised haemolysis
N - non-optimal sucking/feeding
D - deficiency of G6PD
I - infection
C - Cephalhaematoma of bruising
E - ethnicity in particular East Asian heritage, Mediterranean, African. Early birth-preterm .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some key practice point of phototherapy?

A
  • Position phototherapy units no more than 30.5cm from the patient
  • expose as much skin as possible
  • cover eyes but remove to feed and every 6-8hours
  • 4/24 vitals
  • turn unti of when doing TCB or SBR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are some side effects of phototherapy?

A
  • Overheating or hypothermia
  • Waterloss
  • Diarohoea
  • Ileus in perterm newborn
  • Rash- no treatment required
  • Parental separation
  • ‘Bronzing’ of infants with conjugated - hyperbilirubinaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When to cease phototherapy and rechecking protocol?

A
  • when under 50mmol/L of the range.
  • no need to reck check unless risk of rebound including;
    • haemolytic disease
    • gestation less than 37 weeks
    • cessation of phototherapy at less than 72 hours of age.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is an exchange transfusion?

A

= The procedure involves slowly removing the person’s blood and replacing it with fresh donor blood or plasma.
- reccomended to commence in tertiary center
- if TCB>/ exchange line= medical emergency and get baby on intensive phototherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the indication for an exchange transfusion?

A
  • Alloimmune haemolytic disease of the newborn
    • Remove circulating bilirubin to reduce levels and prevent kernicterus
    • Replace antibody-coated red cells with antigen-negative red cells
    • Sever herperbilirubinaemia secondary to alloimmune heamolytic disease is the most common reason for excahnge transfusion in the NICU.
  • Significant unconjugated hyperbilirubinaemia with risk of kernicterus due to any cause when intensive phototherapy is unsuccessful
  • Severe anaemia (where there is normal or increased circulating blood volume)
  • Antibodies in maternal autoimmune disease
  • Polycythaemia (to reduce haematocrit, usually accomplished with partial exchange transfusion using normal saline replacement)
  • Severe disturbances of body chemistry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are some complications of exchange transfusion?

A
  • Catheter related complications
  • air emboli
  • Thrombosis
  • haemorrhage

Other;
- Haemodynamic (related to excess removal of injection of blood)
- hypo or hypertension, intraventricular haemorrhage (preterm)
- Hypo or hyperglycaemia
- Hypocalcaemia
- Hyperkalaemia,
- Acidaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is breastmilk jaundice? what is the cause and what is the teartment?

A

= higher serum bilirubin peaks and slower decline, compared to the hyperbilirubinemia trend associated with other etiologies, leading to longer resolution time.
Cause: exact is unknown. Some evidence to suggest breast milk inhibits the newborn’s liver to process bilirubin and other suggest it is a genetic mutation or delay in entric flora in the breastfed newborns gut.

  • occurs typically in the second week of life.
  • spontaneously resolves even without discontinuation of breastfeeding.
    It can persist for 8-12 weeks of life before resolution.

Treatment: none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is prematurity?

A

= broad category of neonates born alive before 37 completed weeks gestation.

28
Q

What is pre term?

A

extremely preterm
- less than 28 weeks gestation

very preterm
- 28-32 weeks gestation

moderate to late preterm
- 32-36.6 weeks gestation

Late pre term
- 34+0 to 36+6 and/or 2.0-2.5kg birth weight

29
Q

What are some causes of pre term brith?

A
  • of preterm birth
  • Multiple pregnancies
  • Infection
  • Chronic conditions e.g. diabetes, hypertension
    Often the cause is unknown
30
Q

What are some interventions to improve perterm birth outcomes

A
  • Antenatal corticosteroids to improve newborn outcomes
  • Tocolytics to inhibit preterm labour
  • Magnesium Sulphate for fetal protection against neurological complications
  • Antibiotics for pretem labour
  • Optimal mode of delivery
  • Thermal care for preterm newborns
  • Continuous positive airway pressure for newborns with respiratory distress syndrome
  • Surfactant administration for newborns with respiratory distress- intubated and ventilated
  • Oxygen therapy and concentration for preterm newborns.
31
Q

What is the consideration when caring for a 22-23.6 weeker?

A

= zone of parental discretion
- parents deciding what level of care to go ahead with.
- where it is ethically legitimate for parents to make decisions for the care of their child.
- This includes decisions that are not in line with the preferences of the treating team, as long as those decisions will not – on balance – cause significant harm to the child.

  • Present both ethical and clinical challenges e.g. parents deciding what level of care to proivide
32
Q

What factors should be considered when determining management of an extreme pre term?

A
  • Place of birth (tertiary or not)
  • Antenatal corticosteroids exposure
  • Birthweight
  • Plurality
  • Sex
33
Q

What is the management for a late preterm?

A
  • ?SCN
  • monitor as increased risk of illness
  • support feeding
  • lots of skin on skin
  • monitor for;
    - respiratory distress
    - cold stress/thermal instability
    - Sepsis
    - Hypoglycaemia
    - Hyperbilirubinaemia
    - low muscle tone
    - congenital heart disease
    - patent ductus arteriosus (PDA)
    - less stamina
34
Q

Define LBW

A

= <2500g regardless of gestational age

Very low birth weight: <1500 g (regardless of GA)

Extremely low birth weight: <1000 g (regardless of GA)

35
Q

Define IUGR/FGR

A

= a fetus that has not reached its genetically determined growth potential because of a pathological process that has occurred inutero.
= <10 centile
- however when birthweight is >10th centile other clinical features can still suggest FGR (eg asymmetrical growth/“head-sparing”, reduced subcutaneous fat)

  • Reduced growth rate may occur secondary to maternal, placental and/or fetal factors.
    FGR may not have been detected clinically prior to the birt
36
Q

What is management for FGR/SGA?

A

Monitoring and maintenance of:
- Oxygenation
- Temperature
- Blood glucose level
(pink, warm, sweet)
- Cord blood gases should be collected at birth for all suspected SGA/FGR neonates to assess acid base status at birth and whether further review needed for risk of perinatal hypoxia/delayed transition.

37
Q

Define symmetrical FGR

A

= a proportionate decrease in length, weight and head circumference for gestational age, with all parameters less than the 10th percentile on the growth chart

  • usually occurs early in gestation.
38
Q

Define asymmetrical FGR and what it is associated with

A

aka head sparing
= Disproportionate decrease in length and weight compared to the head circumference

  • head circumference= remains appropriate for gestational age
  • Weight and length are decreased (often less than 10th percentile on the growth chart for gestational age)
  • Associated with utero-placental insufficiency and extrinsic factors occurring late in pregnancy (e.g. maternal hypertensive conditions, long standing maternal diabetes, renal disease, smoking and living at a high altitude)
39
Q

What are some anatomical signs of asymmetrical FGR?

A
  • Head disproportionately large for trunk
  • Extremities appear wasted, muscle mass may be decreased especially in the buttocks and thighs
  • Facial appearance of an ‘old man’
  • Large anterior fontanelle with wide or overlapping cranial sutures
  • Thin umbilical cord with diminished Wharton’s jelly
  • Scaphoid abdomen
  • Skin may be loose, thin, dry, flaky and with decreased subcutaneous fat
  • Tone and alertness:
    - Hyper-alert, jittery, hypertonic with mild to moderate FGR
    - Hypotonic with severe FGR
40
Q

What are some anatomical signs of FGR?

A
  • Absence of buccal fat (old man look)
  • Large gead and wide anterior fontenelle
  • Anxioys and hyper alert infant
  • Long finger nails
  • Loose, dry and easy to feel skin
  • Poor skeletal muscle mass and subcutaneous fat with thin arms and legs
  • Loose fold of skin in the nape of the kneck, axillia, interscapular area and groin
  • Relatively lare and thin hands and legs compared to body
  • Thin umbilical cord
  • Poor breast bud formation
41
Q

What are some results of FGR?

A
  • hypothermia
  • hypoglycaemia
  • FDIU
  • retniopathy of prem
  • birth/perinatal asphyxia
  • PPHN
  • mec aspiration
  • NEC
  • renal dysfunction
  • immunodeficiency
    pulmonary haemmorrhage
42
Q

Define NEC?

A

= severe condition where tissues in the lining of the infant’s bowel become inflamed and start to die.

  • A GIT emergency in neonates and may present in advanced stages in tiny babies.
43
Q

Risk factors for NEC?

A
  • very low birth weight neonates
  • most common in babies <1000 g
  • pre-term and growth
    restriced
  • enteral feeding
  • formula feeding - 6 times more common than those only receiving breast milk
  • bowel ischaemia

In term infants
- polycythemia
- cardiac surgery
- abdominal surgery
- gastroschisis, intestinal atresia
- endocrine abnormalities

44
Q

What are some clinical presentations of NEC?

A

GI dysfunction
- abdominal distension, tenderness
- vomiting, often bilious
- feed intolerance with increased aspirate from feeding tubes and may be bilious
- blood in stool

Systemic
- temp instability
- apnoea and/or brady
- lethargy
- hypothension
- acidosis

45
Q

What is the management of NEC before confirmation of diagnosis?

A
  • Nil orally
  • gastric tube on free drainage
  • blood cultures
  • antibitoics
    • vancomycin
    • gentamicin
46
Q

What is the management of NEC once confirmed diagnosis?

A

Antibiotics
- metronidazole if NEC confirmed
- referral to PIPER for consultation and management
- rest gut for 10-14 days
- Total parental nutrition (TPN)
- fluid management
- inotropes
- ventilation
- analgesia
- frequent radiology reviews
- surgery in 25-50% of cases
- Use of probiotics

47
Q

What are some complications of NEC surgery?

A
  • surgery requiring ileostomy
  • Stricture most commonly in the large bowel
48
Q

How can nec be prevented?

A
  • antenatal corticosteroids
  • early intervention and nil orally if suspected NEC
  • breast milk
  • infection control practices to limit disease clusters
49
Q

What are some prenatal risk factors for FGR?

A
  • > 35 years of age
  • nulliparoty
  • IVF singelton
  • indigenous ethnicity
  • substance use e.g. smoking
  • BMI >30
  • previous late >32ks FGR/SGA
  • pre-eclamsia
  • APH
  • congenital infection
  • maternal conditions include chronic hypertension, renal impairment, diabetes with vascular disease
50
Q

What are key points of antenatal management for SGA/FGR?

A
  • Symphyseal fundal height (SFH)
  • Serial plotting of SFH
  • Cardiotocography (CTG)
  • Ultrasound
  • Umbilical Artery Doppler
  • Amniotic fluid volume
51
Q

How do umbilical artery Doppler (UAD) help in the management of SGA/FGR?

A

= measures resistance to blood flow in the umbilical artery and placenta.

The major determinants of FGR based on UAD are:
- increased systolic to diastolic ratio (SD ratio)
- increased pulsatility index (PI)
- absent or reversed end diastolic flow (A/REDF)

52
Q

What are amniotic fluid volumes?

A

= Amniotic fluid volume (AFV) is measured by the single deepest vertical pocket (DVP).

53
Q

What is the ‘5 STEPS’ approach is recommended for care of women who have risk factors for stillbirth at term:

A

S: Stillbirth risk assessment in early pregnancy
T: Tests and further investigation as indicated
E: Evaluate and reassess risk at 34-36+6 weeks
P: Plan for increased surveillance where indicated
S: Support informed, shared decision-making on timing of birth

54
Q

What are some additional considerations that should be made for a fetus who is FGR?

A
  • Use of Oxytocin in labour with caution as FGR/SGA fetuses are at increased risk of acidosis
  • Continuous CTG monitoring if FGR/SGA is suspected
  • Additional support for the neonate at birth and following
  • Review of the placenta post birth- both inspection and weight and the placenta should be sent to histopathology for further review. These results may assist with care of the woman in future pregnancy/s
55
Q

Define SGA

A

= a neonate who has a birth weight more than 2 standard deviations (SD) below the mean or less than the 10th percentile for the appropriate gestational age.

56
Q

Define symmetrical SGA

A
  • Weight, head circumference and length all below the 10th percentile
  • Slow development throughout the pregnancy
  • Limited brain growth
  • These neonates throughout life are often smaller and relatively underweight
  • There appears to be no increased risk of severe neurological morbidity compared to term Appropriate for Gestational Age (AGA) however increased hyperactivity, short attention span and learning problems have been noted
  • These neonates often have an acceleration of growth (catch up) in the first 6 months of life and have normal development
57
Q

What can cause asymmetrical SGA?

A
  • Chromosomal abnormalities
  • Intrauterine infection
  • Severe placental insufficiency
58
Q

What are some fetal related causes of SGA?

A
  • Chromosome disorders: (Trisomy 21, 18, 13)
  • Chronic congenital infection: (CMV, rubella, syphilis, toxoplasmosis)
  • Congenital malformations:
    - congenital heart disease
    - diaphragmatic hernia
    - tracheo-oesophageal fistula
  • Syndrome complex
  • Radiation
  • Multiple gestation relates more to placental limitation rather than intrinsic baby problem
59
Q

What are some maternal related causes of SGA?

A
  • Pregnancy induced hypertension
  • Hypertension, renal disease, or both
  • Hypoxaemia (high altitude, cyanotic cardiac or pulmonary disease)
  • Malnutrition or chronic illness
  • Drugs (narcotics, alcohol, cigarettes, cocaine, antimetabolites)
60
Q

What are some placental related causes of SGA?

A
  • Decreased placental weight, cellularity, or both
  • Decrease in surface area, infarction
  • Villous placentitis (bacterial, viral, parasitic)
  • Tumour (chorioangioma, hydatiform mole)
  • Placental separation
  • Twin to twin transfusion syndrome
61
Q

What are some issues associated with SGA?

A

Intrauterine fetal deminse
- Hypoxia
- Acidosis
- Infection
- Lethal anomaly

Perinatal asphyxia
- Decreased uteroplacental perfusion in labour +/- chronic fetal hypoxia/acidosis

Hypoglycemia
- Decreased tissue glycogen stores
- Decreased gluconeogenesis
- High glucose requirements

Hypothermia
- large SA:V ratio
- poor subcutaneous fat stores

Resp distress
- Intrauterine pneumonia
- Meconium aspiration syndrome
- PPH

62
Q

What are some key points of management for an SGA baby?

A
  • At birth, dry and keep the neonate warm- skin to skin contact is encouraged in a well SGA newborn.
  • Early and effective breastfeeding
  • Prevent hypothermia - Neutral Thermal Environment is important
  • Monitor for hypoglycaemia
  • Effects of neonatal/parental separation
  • The outcome for an SGA neonate is dependent upon the cause
  • SGA expecially pre term SGA are at risk of NEC or GI perforations thus gradually introduce enteral feeds.
63
Q

What should be involved in an assessment of jaundice?

A

Is the neonate unwell?
- Sepsis, GI obstruction
- Ask both parents and visualise baby

Is there dehydration of poor weight gain/excessive weight loss?
- Both exacerbate jaundice

Jaundice before 48 hours of life
- ?haemolysis

Onset of jaundice after 3 days of age
- More likely to be pathological

Birth trauma such as cephalhaematoma, significant bruising
- Breakdown of heme
- More red blood cells on top of own that need to be broken down

Maternal history
- Blood group
- Viral serology

Family history of haemolytic disease
- ABO
- G6PD
- Spherocytosis (abnormal shape RBC)

Dark urine or pale stools
- Suggest biliary obstruction

Level of icterus in terms of cephalocaudal progression
- Jaundice goes form the head down aka cephalocaudal progression
- Kramer’s rule- not always reliable

Plethora
- ?polycythaemia

Hepatosplenomegaly
- Viral hepatitis
- Metabolic issues

64
Q

Why does breast feeding help with bilirubin break down?

A

β glucuronidase in breast milk increases the breakdown of conjugated bilirubin to unconjugated bilirubin in the gut (develops 5-7 days after birth and peaks at 14 days however at 1 month of age up to 10% of breastfed babies remain jaundice)

  • lack of breast milk prevents ability to increase urination
65
Q

Explain breastmilk jaundice and how it can be confirmed

A

Breast milk jaundice
- occur as early as the 3rd day of life
- Peaks late: peaking at 2-3 weeks of age and generally resolves by 3 months of age.

Associated with
- Increase enterohepatic circulation
- Reduced hepatic uptake of unconjugated bilirubin
- Inhibition of Glucuronyl transferase

  • Can only be confirmed once all other pathological conditions have been excluded
66
Q

What is a common SBR reading for pathological jaundice?

A

> 200 mmol/L

67
Q
A
68
Q

When should a TCB not be used?

A
  • if the neonate is receiving phototherapy or has had phototherapy.
  • if ≤ 35 weeks gestation or birth weight < 2000gm
  • in neonates jaundice within the first 24 hours of life
  • in neonates with major clinical risks for hyperbilirubinaemia e.g. cephalhaematoma
  • in neonate with family history or risk factors for haemolysis e.g. ABO or Rh incompatibility, G6PD deficiency.
69
Q

How does phototherapy work?

A

Creates chemical reaction when bilirubin in skin absorbs light- converts bilirubin to a product that can bypass the liver’s conjugating process

Generates yellow stereo-isomers of bilirubin less likely to cross blood brain barrier – excrete in bile or urine

= Used to decrease the level of unconjugated bilirubin to prevent acute bilirubin encephalopathy, hearing loss and kernicterus.